Biosimilar antibodies are research-grade antibodies that are highly similar in structure, function and sequences to the approved original therapeutic antibodies. They are produced through recombination technology and have the same variable regions from the corresponding therapeutic antibodies, which making them reliable and more cost-effective research tools and alternative reagents in drug development and basic research.
CUSABIO has successfully expressed and validated many research-grade biosimilar antibodies, covering a variety of popular targets. All these research-grade biosimilar antibodies can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
Our biosimilar antibodies are recombinantly expressed in mammalian cells with unmodified variable and Fc regions identical to the approved therapeutic antibodies.
We offer over 200 ready-to-use biosimilar antibodies covering key targets, including immune checkpoints, tumor drivers, and neurological markers.
Each batch is ELISA-validated for strong target binding and comes with an EC50 value for reliable performance.
We offer stable supply of research-grade biosimilar antibodies from ul to g level, proving multiple options to customers.
Serve as highly similar research tools for in vitro assessment of biological activities such as cytotoxicity and blocking effects of antibody drugs, enabling in-depth investigation into their mechanisms of action.
Used as critical reference standards or surrogate materials in the development of pharmacokinetic (PK) and immunogenicity (ADA) assays, facilitating method validation and bioequivalence evaluation.
Function as reliable positive controls in Flow Cytometry, IHC, and other detection platforms, or are utilized in the development of companion diagnostics to ensure assay specificity and accuracy.
With formulations suitable for in vivo administration, they can be directly applied in animal models for efficacy assessment and dose exploration, providing a foundation for preclinical research.
Don't see your desired biosimilar in the catalog below? We also offer a High-Throughput Recombinant Antibody Production Service to develop custom antibodies for any target – at the same competitive price point. Learn more
| Code | Product Name |
|---|---|
| CSB-RA017765MB1HU | PEAR1 (SV001 Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA009939MB1HU | GRN (AG-01 Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA044639I1m | GD3 ganglioside (Ecromeximab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA320223MA1BQE | pagA Antigen (Obiltoxaximab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA336462MA1FKZ | spa (Omodenbamab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA853494MA2HU | FCRL5 (DFRF4539A (RG-7598) Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA011880MA1HU | ITGB1 (OS-2966 Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA898797MA1HU | TAG-72 (Minretumomab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA005983MA2HU | CRLF2 (Solrikitug Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA621524MA1HU | KLRB1 (Rezorstobart Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA015950MA2HU | NOTCH2 (Tarextumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA006045MA3HU | CSF2 (Namilumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA004953MA1HU | CD7 (Grisnilimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA801822MA2HU | VTCN1 (Puxitatug Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA704410MA3HU | MUC16 (Sofituzumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA867155MA2HU | SLITRK6 (Sirtratumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA154670MA1HU | IgE (Talizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA592139MA1HU | OxLDL (Orticumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA012928MA1HU | LIF (Falbikitug Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA357716MA1FKZ | Toxin A (Tosatoxumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA004943MA2HU | CD52 (Gatralimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA012871MA1HU | LEPR (Mibavademab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA016331MA1HU | OLR1 (Golocdacimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA003658MA1HU | C2 (Empasiprubart Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA011050MA2HU | IFNG (Fontolizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA011864MA2HU | ITGA2 (Vatelizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA004900MA1HU | CD22 (Moxetumomab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA007765MA2HU | ERBB3 (Duligotuzumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA872537MA2HU | IL21 (Avizakimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA023462MA2HU | TGM2 (Zampilimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA011661MA2HU | IL4R (Manfidokimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA003995MA2HU | C5 (Crovalimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA621767MA2HU | SELPLG (Neihulizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA023446MA1HU | TGFB1 (Metelimumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA984018MA1DO | IL-31 (Lokivetmab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA011087MA3HU | IGF1R (Figitumumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA890691MA2HU | STEAP1 (Vandortuzumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA16849MA2HU | IGHE (Quilizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA004895MA2HU | CD200 (Samalizumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA618886MA1HU | LRRC32 (Livmoniplimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA007717MA2HU | EPCAM (Tucotuzumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA159341MB20HU | EGFR (Tomuzotuximab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA017647MB13HU | PCSK9 (Frovocimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA614985MB1HU | AMHR2 (Murlentamab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA675446MB18HU | TIGIT (Tamgiblimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA012719MB16HU | LAG3 (Ieramilimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA619964MB54HU | PDCD1 (Acrixolimab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA878862MB3HU | DLL4 (Enoticumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA887154MB1HU | RSPO3 (Rosmantuzumab Biosimilar) Recombinant Monoclonal Antibody |
| CSB-RA015215MB3HU | MUC1 (Gatipotuzumab Biosimilar) Recombinant Monoclonal Antibody |